April Drug Price Revision “Will Be a Hard One” for the Industry: Pharma Leader Nakayama

January 7, 2016
Joji Nakayama, Head of Pharmaceutical Manufacturers’ Association of Tokyo Joji Nakayama, president of Daiichi Sankyo, said on January 6 that the next NHI price revision “will be a hard one” for the industry due to the decision to introduce a...read more